Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955461 · ClinicalTrials.gov registry record · NA
Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System
A NA study, sponsored by ConBio, a Cynosure Company.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00955461 is a NA study that has completed, run by ConBio, a Cynosure Company. The registered enrollment target is 12 participants.
The verdict
NCT00955461, a NA study, has completed, sponsored by ConBio, a Cynosure Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the results of treatment between the side of the face treated with the RevLite Laser and the side of the face treated with a fractionated laser system.
Interventions
- PROCEDURE RevLite laser treatment
- PROCEDURE Fractionated Laser treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00955461
The ClinicalTrials.gov registry entry for NCT00955461 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ConBio, a Cynosure Company, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RevLite laser treatment is the first listed.
NCT00955461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00955461 about?
NCT00955461 is a clinical study titled "Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System". The purpose of this study is to compare the results of treatment between the side of the face treated with the RevLite Laser and the side of the face treated with a fractionated laser system.
What is the current status of trial NCT00955461?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-12. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00955461?
The interventions under investigation include: RevLite laser treatment (PROCEDURE), Fractionated Laser treatment (PROCEDURE).
Who is sponsoring clinical trial NCT00955461?
This trial is sponsored by ConBio, a Cynosure Company, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.